CBD for Dementia: A Phase 2/3 Study
Part of Brain & nervous system, Heart & circulation, Mental health clinical trials.
This trial tests whether cannabidiol (CBD) can help manage dementia symptoms. It is for people 50 or older with mild to severe dementia who have a caregiver to support them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 50 or older
- You must have a doctor's diagnosis of mild to severe dementia
- Your condition must be stable (for example, no recent bad seizures)
- Your caregiver must agree to help with the study, give consent, and bring you to visits
- You cannot be using certain drugs or medications that might interact with CBD
- You cannot have serious heart, liver, kidney, or mental health problems
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study tests whether CBD (a cannabis-derived product) can improve thinking and memory in people who are at risk for Alzheimer’s disease. You would be followed for about 24 weeks with memory/thinking check-ins and require a study partner to help with certain assessments.
This trial studies whether a THC-free CBD oil softgel can reduce agitation in people with Alzheimer’s-related dementia. It compares CBD to a control to see if it improves difficult behaviors and is safe over the study period.
This study tests if a CBD medication can help reduce agitation in people with Alzheimer's disease. It's for adults 55 and older who have significant agitation and mild to moderate dementia.
This trial tests whether cannabidiol (CBD) can help reduce burnout and improve empathy in people who care for older adults. You will take CBD daily for a period and complete surveys to see if it helps you feel less exhausted and more connected.
This trial tests whether cannabidiol (CBD) can help with Parkinson's disease symptoms. Researchers want to see if it's safe and effective for people with mild to moderate Parkinson's who are already on stable medications.
This study tests whether a pure CBD product (Epidiolex) can help older adults who use cannabis occasionally. It looks at how CBD affects people who already take medications for pain, sleep, or mood issues.
Hear when a new Dementia, Mixed trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.